Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Bacteria‐derived ferrichrome inhibits tumor progression in sporadic colorectal neoplasms and colitis‐associated cancer

Fig. 5

The in vivo acute toxicity level of intravenously administered ferrichrome. The serum was collected from the inferior vena cava of 300 mg/kg ferrichrome-treated mice, and biochemical tests were performed. There were no significant changes in the test values of AST, ALT, creatinine or iron. *p < 0.05 by Student’s t-test. The error bars show the standard deviation (S.D.)

Back to article page